High frequency of Clostridium difficile diarrhea among patients with renal diseases;Alta incidencia de diarrea por Clostridium difficile en pacientes nefrológicos

Revista Medica de Chile

Volumn 131, Issue 4, 2003, Pages 397-403

  Herrera R, Patricia ^a   Cotera F, Alejandro ^a   Fica C, Alberto ^a   Galdo A, Teresa ^a   Alvo A, Miriam ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Clostridium difficile; Enterocolitis, pseudomembranous; Kidney failure, chronic

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN; METRONIDAZOLE; QUINOLONE;

ADULT; AGED; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS; HOSPITAL; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY DISEASE; KIDNEY GRAFT; MALE; MORBIDITY; RECURRENCE RISK; REVIEW; RISK FACTOR; TREATMENT OUTCOME; UREMIA; ARTICLE; CHILE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PSEUDOMEMBRANOUS COLITIS; RECURRENT DISEASE; RETROSPECTIVE STUDY;

ANTI-BACTERIAL AGENTS; CHILE; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 0042734686     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. BARTLETT J, CHANG T, GUNWITH M, GORBACH S, ONDERDONK A. Antibiotic associated pseudomembranous colitis due to toxin producing clostridia. N Engl J Med 1978; 298: 531-4.
2. BARTLETT J. Antibiotic-associated diarrhea. N Engl J Med 2002; 346: 334-9.
3. KELLY C, PHOTOLAUKIS C, LAMONT J. Clostridium difficile colitis. N Engl J Med 1994; 330: 257-62.
4. GERDING D, JOHNSON S, PETERSON L, MULLIGAN M, SILVA J. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995; 16: 459-77.
5. MCFARLAND L, MULLIGAN M, KWOK R, STAMM W. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320: 204-10.
6. KYNE L, HAMEL M, POLAVARAM R, KELLY C. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002; 34: 346-53.
7. KYNE L, WARNY M, QAMAR A, KELLY C. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000; 342: 390-7.
8. KYNE L, MERRY C, O'CONNELL B, KELLY A, KEANE C, O'NEILL D. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing 1999; 28: 107-13.
9. KENT K, RUBIN M, WROBLEWESKI L, HANFF P, SILEN W. The impact of Clostridium difficile on a surgical service: a prospective study of 374 patients. Ann Surg 1998; 227: 296-301.
10. GARDILCIC M, FICA A, CHANG M, LLANOS C, LUZORO A. Diarrea asociada a Clostridium difficile en un hospital de adultos. Estudio descriptivo. Rev Chil Infectol 2000; 17: 307-12.
11. POTHOULAKIS C, GALILI U, CASTAGLIUOLO I, KELLY C, NIKULASSON S, DUDEJA P ET AL. A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon. Gastroenterology 1996; 110: 1704-12.
12. LIMAYE A, TURGEON D, COOKSON B, FRITSCHE T. Pseudomembranous colitis caused by toxin A (-) B (+) strain of Clostridium difficile. J Clin Microbiol 2000; 38: 1696-7.
13. MCFARLAND L, SURAWICZ C, STAMM W. Risk factors for Clostridium difficile carriage and C difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990; 162: 678-84.
14. HIRSCHHORN L, TRNKA Y, ONDERDONK A. Epidemiology of community acquired Clostridium difficile-associated diarrea. J Infect Dis 1994; 109: 127-33.
15. VISCIDI R, WILLEY S, BARTLETT J. Isolation rates and toxigenic potencial of Clostridium difficile isolates from various patient populations. Gastroenterology 1981; 81: 5-9.
16. JOBE B, GRASLEY A, DEVENEY K, DEVENEY C, SHEPPARD B. Clostridium difficile colitis: an increasing hospital acquired illness. Am J Surg 1995; 169: 480-3.
17. BARANY P, STENVINKEL P, NORD CE, BERGSTROM J. Clostridium difficile infection; a poor prognostic sign in uremic patients? Clin Nephrol 1992; 38: 53-7.
18. BARLETT J. Antibiotic-associated diarrhea. Clin Infect Dis 1992; 15: 573-81.
19. KARLSTROM O, FRYKLUND B, TULLUS K, BURMAN L. A prospective nation wide study of Clostridium difficile-associated diarrhea in Sweden. Clin Infect Dis 1998; 26: 141-5.
20. ALVAREZ M, GONZÁLEZ R, BRICEÑO I. Diagnóstico de diarrea por Clostridium difficile: en busca de un enfoque clínico más eficiente. Rev Méd Chile 2000; 129: 620-5.
21. BLISS D, JOHNSON S, SAVIK K, CLABOTS C, WILLARD K, GERDING D. Acquisition of Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med 1998; 129: 1012-9.
22. BUCHNER A, SONNENBERG A. Medical diagnoses and procedures associated with Clostridium difficile colitis. Am J Gastroenterol 2001; 96: 766-72.
23. RUBIN M, BODENSTEIN L, KENT K. Severe Clostridium difficile colitis. Dis Col Rectum 1995; 38: 350-4.
24. CUNNEY R, MAGEE C, MCNAMARA E, SMYTH E, WALSHE J. Clostridium difficile colitis associated with chronic renal failure. Nephrol Dial Transplant 1998; 13: 2842-6.
25. POPOOLA J, SWANN A, WARWICK G. Clostridium difficile in patients with renal failure management of an outbreak using biotherapy. Nephrol Dial Transplant 2000; 15: 571-4.
26. SAMORE M, VENKATARAMAN L, DEGIROLAMI P, ARBEIT R, KARCHMER A. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996; 100: 32-40.
27. KIM K, FEKETY R, BATTS D, CUDMORE M, SILVA J, WATERS D. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic associated colitis. J Infect Dis 1981; 143: 42-50.
28. FEKETY R, KIM K, BROWN D, CUDMORE M, SILVA J. Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment. Am J Med 1981; 70: 906-8.
29. BRICEÑO I, GARCÍA P, ALVAREZ M, FERRES M, QUIROGA T. Diarrea asociada a Clostridium difficile: Evaluación de varios métodos de diagnóstico. Rev Chil Infectol 2000; 17: 313-20.
30. FICA A, LUZORO A, LLANOS C. Brote de infección intrahospitalaria por Clostridium difficile. Revista Hospital Clínico U de Chile 1999; 10: 328-32.
31. KYNE L, WARNY M, QAMAR A, KELLY C. Asociation between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhea. Lancet 2001; 357: 189-93.
32. KOTLOFF K, WASSERMAN S, LOSONSKY G, THOMAS W, NICHOLS R, EDELMAN R ET AL. Safety and inmunogenicity of increasing doses of Clostridium difficile toxoid vaccine administered to healthy adults. Infect Immun 2001; 69: 988-95.
33. WENISCH C, PARSCHALK B, HASENHUNDL M, HIRSCHL A, GRANINGER W. Comparison of vancomycin, teicoplanis, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996; 22: 813-8.
34. WOLFF M. Diarrea asociada a antibióticos: ¿un mal inevitable? Rev Chil Infect 1996; 13: 69-74.
35. KELLY C. Immune response to Clostridium difficile infection. Eur J Gastroenterol Hepatol 1996; 8: 1048-53.
36. TEDESCO F, GORDON D, FORTSON W. Approach to patients with multiple relapses of antibiotic-associated pseudomenbranous colitis. Am J Gastroenterol 1985; 80: 867-8.
37. DO A, FRIDKIN S, YECHOURON A, BANERJEE S, KILLGORE G, BOURGAULT A ET AL. Risk factors for early recurrent Clostridium difficile-associated diarrhea. Clin Infect Dis 1998; 26: 954-9.